Systemic Erythropoietin Injection in Patients Having Optic Atrophy

• Status: Completed
• Trial end date: 2021-03-30
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this treatment trial is to study the effect of systemic erythropoietin in patients having optic atrophy.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Alexandria University
• Treatments: Epoetin Alfa

Criteria

Inclusion Criteria:

• Post papilledemic optic atrophy patients

Exclusion Criteria:

• Refuse to give an informed consent